Boule Diagnostics AB (ST:BOUL) — Stock Price

Skr3.60 SEK
▲ 0.00% today

Boule Diagnostics AB (ST:BOUL) is currently trading at Skr3.60 SEK, up 0.00% today. Over the past 52 weeks, shares have ranged between Skr3.15 and Skr6.48. This page tracks Boule Diagnostics AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Boule Diagnostics AB.

Boule Diagnostics AB (BOUL) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Boule Diagnostics AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Boule Diagnostics AB Income Statement — Revenue, Profit & Earnings by Year

Boule Diagnostics AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr558.60 Million Skr571.33 Million Skr548.09 Million Skr463.34 Million Skr400.46 Million
Cost of Revenue Skr306.20 Million Skr321.62 Million Skr320.18 Million Skr264.71 Million Skr223.27 Million
Gross Profit Skr252.40 Million Skr249.71 Million Skr227.91 Million Skr198.63 Million Skr177.19 Million
Research & Development Skr307.20 Million Skr53.09 Million Skr51.57 Million Skr43.33 Million Skr83.10 Million
SG&A Skr36.20 Million Skr32.66 Million Skr32.87 Million Skr31.47 Million Skr27.99 Million
Total Operating Expenses Skr509.80 Million Skr210.40 Million Skr194.43 Million Skr162.78 Million Skr181.64 Million
Operating Income Skr-257.40 Million Skr39.30 Million Skr28.97 Million Skr36.02 Million Skr-4.45 Million
EBITDA Skr-255.90 Million Skr65.98 Million Skr57.84 Million Skr55.69 Million Skr16.98 Million
EBIT Skr-278.84 Million Skr41.36 Million Skr30.67 Million Skr34.22 Million Skr-4.57 Million
Interest Expense Skr12.60 Million Skr11.30 Million Skr9.82 Million Skr5.45 Million Skr4.06 Million
Income Before Tax Skr-268.50 Million Skr30.10 Million Skr20.85 Million Skr28.77 Million Skr-49.02 Million
Income Tax Expense Skr-45.20 Million Skr5.12 Million Skr8.12 Million Skr5.50 Million Skr-1.06 Million
Net Income Skr-223.30 Million Skr24.98 Million Skr12.73 Million Skr23.27 Million Skr-47.97 Million

Boule Diagnostics AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Boule Diagnostics AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr590.20 Million Skr755.11 Million Skr759.96 Million Skr572.03 Million Skr479.71 Million
Total Current Assets Skr254.80 Million Skr279.93 Million Skr338.41 Million Skr242.38 Million Skr196.62 Million
Cash & Equivalents Skr22.65 Million Skr37.28 Million Skr96.90 Million Skr38.18 Million Skr32.99 Million
Short-term Investments Skr3.78 Million Skr-56.00K Skr-45.80 Million Skr-36.82 Million Skr-36.82 Million
Net Receivables Skr167.40 Million Skr155.15 Million Skr157.65 Million Skr132.44 Million Skr103.31 Million
Inventory Skr59.10 Million Skr62.41 Million Skr75.27 Million Skr59.04 Million Skr54.54 Million
Property, Plant & Equipment Skr39.48 Million Skr44.27 Million Skr58.57 Million Skr47.42 Million Skr54.74 Million
Goodwill Skr91.92 Million Skr85.45 Million Skr88.12 Million Skr78.69 Million Skr72.91 Million
Total Liabilities Skr320.60 Million Skr280.01 Million Skr297.46 Million Skr276.30 Million Skr210.41 Million
Total Current Liabilities Skr262.50 Million Skr203.00 Million Skr201.03 Million Skr211.20 Million Skr152.73 Million
Long-term Debt Skr51.40 Million Skr57.74 Million Skr62.07 Million Skr35.70 Million Skr17.80 Million
Net Debt Skr172.30 Million Skr128.89 Million Skr93.06 Million Skr117.26 Million Skr92.50 Million
Total Stockholder Equity Skr269.60 Million Skr475.10 Million Skr462.50 Million Skr295.74 Million Skr269.30 Million
Retained Earnings Skr-124.80 Million Skr98.53 Million Skr73.56 Million Skr71.51 Million Skr58.91 Million

Boule Diagnostics AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Boule Diagnostics AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr46.60 Million Skr51.38 Million Skr-11.35 Million Skr43.28 Million Skr75.24 Million
Capital Expenditures Skr85.90 Million Skr82.70 Million Skr74.96 Million Skr56.37 Million Skr46.01 Million
Free Cash Flow Skr-39.30 Million Skr-31.30 Million Skr-86.31 Million Skr-13.09 Million Skr29.23 Million
Investing Cash Flow Skr-85.90 Million Skr-82.71 Million Skr-74.96 Million Skr-56.37 Million Skr-46.01 Million
Financing Cash Flow Skr24.40 Million Skr-25.51 Million Skr140.55 Million Skr15.75 Million Skr-14.88 Million
Dividends Paid — Skr0.00 Skr10.68 Million Skr10.68 Million Skr10.68 Million
Stock-Based Compensation — — — — —
Depreciation Skr22.94 Million Skr24.61 Million Skr27.18 Million Skr21.48 Million Skr21.55 Million
Change in Cash Skr-14.60 Million Skr-59.62 Million Skr58.72 Million Skr5.19 Million Skr11.41 Million

Boule Diagnostics AB Earnings History — EPS Actual vs. Analyst Estimates

Track Boule Diagnostics AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 27, 2026 — — —
Oct 24, 2025 0.18 0.12 +50.00%
Jul 18, 2025 -0.03 0.22 -113.64%
Apr 28, 2025 0.35 0.39 -10.26%
Feb 11, 2025 0.33 0.29 +12.45%
Oct 25, 2024 0.26 0.17 +52.94%
Jul 22, 2024 0.17 0.24 -29.17%
May 07, 2024 0.25 0.12 +108.33%